Medtronic Raises 2027 Forecasts Amid Heart Device Demand Surge

Medtronic has revised its fiscal 2027 financial outlook upwards, citing increased demand for its heart devices used in complex cardiovascular procedures. The company now anticipates annual organic revenue growth between 7.25% and 7.75%, up from the previous forecast of 6.75% to 7.25%. The lower end of its adjusted per-share profit forecast has also been raised to $5.94 from $5.90, while the upper limit remains at $6.

Strategic Investments and Market Expansion

In addition to its revised forecasts, Medtronic announced significant investments aimed at expanding its market presence. The company plans to invest $80 million in Pi-Cardia, a heart-valve repair device maker, with an option to acquire it for $210 million. Furthermore, Medtronic has committed $700 million to Cornerstone Robotics, securing distribution rights for a robotic surgical device in select international markets.

Geoff Martha, Medtronic's CEO, highlighted the strategic focus on high-growth segments within the medtech industry. "We are prioritizing segments with large patient pools and significant growth potential," Martha stated. The investments align with Medtronic's strategy to enhance its product offerings in emerging markets, where soft tissue robotic surgery penetration remains below 1%.

Strong Performance in Cardiovascular Segment

Medtronic's cardiovascular segment reported a notable 19.5% increase in quarterly sales, reaching $3.93 billion. This growth was largely driven by an 88% surge in its pulsed field ablation portfolio, which is used to treat irregular heart rhythms. The company posted an adjusted quarterly per-share profit of $1.45 on revenue of $9.76 billion, surpassing analyst expectations of $1.39 per share on $9.55 billion in sales, according to data compiled by LSEG.

Thierry Pieton, Medtronic's Chief Financial Officer, mentioned that the company received tariff refunds that almost offset the duties paid during the quarter. However, these refunds have not been factored into future financial projections.

Future Outlook

Medtronic's strategic investments and robust performance across its business segments underscore its confidence in sustained growth. The company's focus on innovation and expansion into high-potential markets is expected to drive future success. As Medtronic continues to capitalize on the rising demand for advanced medical technologies, its financial outlook remains optimistic.